Our next #RheumJC discussion will be Thursday, February 23rd, discussing the January 2017 Arthritis & Rheumatology article: Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study) by Dr. Kenneth G. Saag, et al. This article is open-access.
- First session: 4pm Eastern Time (find this in your time zone)
- Second second: 10pm Eastern Time (find this in your time zone)
If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.
We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.
- Please remember to try to stay on topic whenever possible.
- Be polite and courteous.
- Do not violate HIPAA.
We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at email@example.com.